Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7489935 [patent_doc_number] => 20110237450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHODS AND SYSTEMS OF USING EXOSOMES FOR DETERMINING PHENOTYPES' [patent_app_type] => utility [patent_app_number] => 13/009393 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 149 [patent_figures_cnt] => 149 [patent_no_of_words] => 80474 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237450.pdf [firstpage_image] =>[orig_patent_app_number] => 13009393 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/009393
Methods and systems of using exosomes for determining phenotypes Jan 18, 2011 Issued
Array ( [id] => 8270154 [patent_doc_number] => 08211653 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Methods and systems of using exosomes for determining phenotypes' [patent_app_type] => utility [patent_app_number] => 13/009285 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 149 [patent_figures_cnt] => 79 [patent_no_of_words] => 80474 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13009285 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/009285
Methods and systems of using exosomes for determining phenotypes Jan 18, 2011 Issued
Array ( [id] => 8397926 [patent_doc_number] => 08268308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Means for the diagnosis and therapy of CTCL' [patent_app_type] => utility [patent_app_number] => 13/008406 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 20983 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13008406 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/008406
Means for the diagnosis and therapy of CTCL Jan 17, 2011 Issued
Array ( [id] => 9662023 [patent_doc_number] => 08808997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Lung cancer markers, and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/005031 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 55340 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005031 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/005031
Lung cancer markers, and uses thereof Jan 11, 2011 Issued
Array ( [id] => 8606081 [patent_doc_number] => 20130011393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'BAD PATHWAY GENE SIGNATURE' [patent_app_type] => utility [patent_app_number] => 13/519544 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 24577 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519544 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/519544
BAD PATHWAY GENE SIGNATURE Jan 11, 2011 Abandoned
Array ( [id] => 6047542 [patent_doc_number] => 20110207136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR' [patent_app_type] => utility [patent_app_number] => 13/005127 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11740 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207136.pdf [firstpage_image] =>[orig_patent_app_number] => 13005127 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/005127
Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR Jan 11, 2011 Abandoned
Array ( [id] => 8755249 [patent_doc_number] => 20130089554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'RON Binding Constructs and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/519675 [patent_app_country] => US [patent_app_date] => 2010-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 36362 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519675 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/519675
RON Binding Constructs and Methods of Use Thereof Dec 28, 2010 Abandoned
Array ( [id] => 8431029 [patent_doc_number] => 20120252904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'MITF AS A MARKER FOR PREDISPOSITION TO CANCER' [patent_app_type] => utility [patent_app_number] => 13/515984 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8465 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515984 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/515984
MITF as a marker for predisposition to cancer Dec 20, 2010 Issued
Array ( [id] => 6038438 [patent_doc_number] => 20110091487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'MELANOMA BIOMARKER AND METHODS OF USES' [patent_app_type] => utility [patent_app_number] => 12/971106 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16041 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091487.pdf [firstpage_image] =>[orig_patent_app_number] => 12971106 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/971106
MELANOMA BIOMARKER AND METHODS OF USES Dec 16, 2010 Abandoned
Array ( [id] => 6125367 [patent_doc_number] => 20110086022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Methods for diagnosing and treating neuroendocrine cancer' [patent_app_type] => utility [patent_app_number] => 12/962177 [patent_app_country] => US [patent_app_date] => 2010-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13688 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086022.pdf [firstpage_image] =>[orig_patent_app_number] => 12962177 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/962177
Methods for diagnosing and treating neuroendocrine cancer Dec 6, 2010 Issued
Array ( [id] => 6142221 [patent_doc_number] => 20110129482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/952593 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 106 [patent_figures_cnt] => 106 [patent_no_of_words] => 40173 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952593 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/952593
POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH Nov 22, 2010 Abandoned
Array ( [id] => 8916890 [patent_doc_number] => 20130178515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'PREDICTIVE MARKERS FOR TAXANE RESPONSIVENESS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/510799 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10856 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510799 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/510799
Predictive markers for taxane responsiveness and methods of use thereof Nov 18, 2010 Issued
Array ( [id] => 9389045 [patent_doc_number] => 08685640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Medical methods and agents for use therein' [patent_app_type] => utility [patent_app_number] => 13/510565 [patent_app_country] => US [patent_app_date] => 2010-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 11 [patent_no_of_words] => 14936 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510565 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/510565
Medical methods and agents for use therein Nov 16, 2010 Issued
Array ( [id] => 6080072 [patent_doc_number] => 20110142828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'TREATMENT PREDICTION INVOLVING HMGCR' [patent_app_type] => utility [patent_app_number] => 12/946934 [patent_app_country] => US [patent_app_date] => 2010-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32076 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142828.pdf [firstpage_image] =>[orig_patent_app_number] => 12946934 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/946934
Treatment prediction involving HMGCR Nov 15, 2010 Issued
Array ( [id] => 6111282 [patent_doc_number] => 20110189711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'PAAD DOMAIN-CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/942975 [patent_app_country] => US [patent_app_date] => 2010-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 35841 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189711.pdf [firstpage_image] =>[orig_patent_app_number] => 12942975 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/942975
PAAD DOMAIN-CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE Nov 8, 2010 Abandoned
Array ( [id] => 11232030 [patent_doc_number] => 09459254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-04 [patent_title] => 'Method for determining sensitivity to an anticancer agent' [patent_app_type] => utility [patent_app_number] => 13/505143 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9101 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 555 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505143 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/505143
Method for determining sensitivity to an anticancer agent Oct 28, 2010 Issued
Array ( [id] => 6070156 [patent_doc_number] => 20110045006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'LUCA2 and Antibodies That Bind Thereto' [patent_app_type] => utility [patent_app_number] => 12/915842 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24328 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045006.pdf [firstpage_image] =>[orig_patent_app_number] => 12915842 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/915842
LUCA2 and Antibodies That Bind Thereto Oct 28, 2010 Abandoned
Array ( [id] => 7575701 [patent_doc_number] => 20110271357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'COLON DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/911617 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42396 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20110271357.pdf [firstpage_image] =>[orig_patent_app_number] => 12911617 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/911617
COLON DISEASE TARGETS AND USES THEREOF Oct 24, 2010 Abandoned
Array ( [id] => 6040913 [patent_doc_number] => 20110093962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'BREAST DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/910390 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42889 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20110093962.pdf [firstpage_image] =>[orig_patent_app_number] => 12910390 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/910390
BREAST DISEASE TARGETS AND USES THEREOF Oct 21, 2010 Abandoned
Array ( [id] => 6063051 [patent_doc_number] => 20110201012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSING EPITHELIAL CELL CANCER' [patent_app_type] => utility [patent_app_number] => 12/907370 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 19025 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201012.pdf [firstpage_image] =>[orig_patent_app_number] => 12907370 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/907370
METHODS AND COMPOSITIONS FOR DIAGNOSING EPITHELIAL CELL CANCER Oct 18, 2010 Abandoned
Menu